Addison's Disease
What's New
Last Posted: May 09, 2024
- Roles of blood metabolites in mediating the relationship between vitiligo and autoimmune diseases: Evidence from a Mendelian randomization study.
Siyu Yang, et al. International immunopharmacology 2024 0 112132 - Analysis of a series of Italian APECED patients with autoimmune hepatitis and gastro-enteropathies.
Giorgia Paldino, et al. Frontiers in immunology 2023 0 1172369 - Genetic variants and risk for the endocrine autoimmunity in relatives of patients with Addison's disease.
Fichna Marta, et al. Endocrine connections 2023 0 - Replication of association at the LPP and UBASH3A loci in a UK autoimmune Addison's disease cohort.
Howarth Sophie, et al. European journal of endocrinology 2023 0 (1) - High-dose vitamin D in Addison's disease regulates T-cells and monocytes: A pilot trial.
Penna-Martinez Marissa, et al. Nutrition (Burbank, Los Angeles County, Calif.) 2018 0 66-73 - DLA class II risk haplotypes for autoimmune diseases in the bearded collie offer insight to autoimmunity signatures across dog breeds.
Gershony Liza C, et al. Canine genetics and epidemiology 2019 0 2 - Polymorphisms in the CTLA4 promoter sequence are associated with canine hypoadrenocorticism.
Boag Alisdair M, et al. Canine medicine and genetics 2020 0 2 - Polymorphism in BACH2 gene is a marker of polyglandular autoimmunity.
Fichna Marta, et al. Endocrine 2021 0 (1) 72-79 - Insilico prediction and functional analysis of nonsynonymous SNPs in human CTLA4 gene.
Irfan Muhammad, et al. Scientific reports 2022 0 (1) 20441 - Monocytic Cytokines in Autoimmune Polyglandular Syndrome Type 2 Are Modulated by Vitamin D and HLA-DQ.
Kraus Anna U, et al. Frontiers in immunology 2020 0 583709 - [Autoimmune polyendocrine syndrome type 2 associated with autoimmune hypophysitis and coeliac disease].
Hrubisková K, et al. Vnitrni lekarstvi 2011 0 (11) 1169-76 - Severe weight loss in a hypothyroid patient as an acute presentation of autoimmune polyglandular syndrome type II.
Silajdzija Elvira, et al. Hormones (Athens, Greece) 2022 0 (2) 317-322 - Aggregation of autoimmunity in extended families of people with autoimmune Addison's disease.
Fichna Marta et al. Internal medicine journal 2021 - GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility.
Eriksson Daniel, et al. Nature communications 2021 0 (1) 959 - Vitamin D status and pathway genes in five European autoimmune Addison's disease cohorts.
Penna-Martinez Marissa, et al. European journal of endocrinology 2021 1 - Association of Vitamin D Pathway Gene CYP27B1 and CYP2R1 Polymorphisms with Autoimmune Endocrine Disorders: A Meta-Analysis.
Ma Xiaoxi, et al. The Journal of clinical endocrinology and metabolism 2020 11 (11) - Amino Acid Polymorphisms in Hla Class II Differentiate Between Thyroid and Polyglandular Autoimmunity.
Frommer Lara, et al. The Journal of clinical endocrinology and metabolism 2019 11 - Meta-analysis of the association between NLRP1 polymorphisms and the susceptibility to vitiligo and associated autoimmune diseases.
Li Juan, et al. Oncotarget 2017 10 (50) 88179-88188 - Vitamin D effects on monocytes' CCL-2, IL6 and CD14 transcription in Addison's disease and HLA susceptibility.
Kraus A U, et al. The Journal of steroid biochemistry and molecular biology 2018 0 53-58 - MAVS is not a Likely Susceptibility Locus for Addison's Disease and Type 1 Diabetes.
Zurawek Magdalena, et al. Archivum immunologiae et therapiae experimentalis 2017 6 (3) 271-274 - Association of PTPN22 1858C/T Polymorphism with Autoimmune Diseases: A Systematic Review and Bayesian Approach.
Tizaoui Kalthoum, et al. Journal of clinical medicine 2019 3 (3) - CLINGEN Actionability Report for Adrenoleukodystrophy - ABCD1
ClinGen Actionability Working Group - Common genetic variation in the autoimmune regulator (AIRE) locus is associated with autoimmune Addison's disease in Sweden.
Eriksson Daniel, et al. Scientific reports 2018 5 (1) 8395 - A Variant in the BACH2 Gene Is Associated With Susceptibility to Autoimmune Addison's Disease in Humans.
Pazderska Agnieszka, et al. The Journal of clinical endocrinology and metabolism 2016 9 jc20162368 - From Genetic Predisposition to Molecular Mechanisms of Autoimmune Primary Adrenal Insufficiency.
Falorni Alberto, et al. Frontiers of hormone research 2016 0 115-32 - Polymorphic variants of the HSD11B1 gene may be involved in adverse metabolic effects of glucocorticoid replacement therapy in Addison's disease.
Fichna Marta, et al. European journal of internal medicine 2016 4 - Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
Fichna Marta, et al. Endocrine 2016 3 - Polymorphisms of the GR and HSD11B1 genes influence body mass index and weight gain during hormone replacement treatment in patients with Addison's disease.
Molnár Ágnes, et al. Clinical endocrinology 2016 1 - Polymorphisms of the Toll-Like Receptor-3 Gene in Autoimmune Adrenal Failure and Type 1 Diabetes in Polish Patients.
Fichna Marta, et al. Archivum immunologiae et therapiae experimentalis 2015 8 - A novel FoxD3 Variant Is Associated With Vitiligo and Elevated Thyroid Auto-Antibodies.
Schunter Jo Ana, et al. The Journal of clinical endocrinology and metabolism 2015 8 jc20152126
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: